View this article online at www.insightplus.mja.com.au
In sweeping reforms to the National Disability Insurance Scheme (NDIS) announced today, the government will cut 160,000 participants from the scheme over the next four years and reduce funding for the average plan by A$5,000 in the next two years.
A study led by the University of Queensland has analysed how genes can affect a child's body mass index (BMI) over time. The research also explores how these genetic factors may increase the risk of developing diseases such as heart disease or type 2 diabetes later in life.
Sarah* is 34, works in administration, and has spent two years without a diagnosis. Her symptoms began with cognitive episodes — words vanishing from her screen mid-sentence and memory lapses — followed by functional seizures and right-sided weakness requiring emergency department care. CT scans and an MRI were unremarkable. She was variously labelled with migraine and anxiety and referred back to her GP. Patients like Sarah are common, yet our health system offers no clear pathway for their care.
Syphilis cases are on the rise, and inconsistent screening in general practice is leaving people at risk.
Australia has made significant advances in the prevention of cervical cancer, but progress on other gynaecological cancers is falling behind.
Eating disorders are complex mental illnesses affecting over 1.1 million people in Australia every year. Medical practitioners play an important role in the treatment team, and knowing where to refer patients for more intensive care is vital.
The Australian Health Biobank is Australia’s first national general population biobank. It provides an unprecedented opportunity to capture population-level trends in disease states and/or environmental exposures, and accelerate integration of scientific discoveries into policy, clinical practice, and future health innovations.
For 25 years, Doctors for the Environment Australia (DEA) has championed a once under-recognised argument: protecting the environment is fundamental to protecting human health.
Clinicians need to be aware of the growing grey market of injectable peptide-based substances being promoted online for weight loss.
